-
Breast Cancer Subtyping Kits Market Forecast 2026-2036: Market Size, Share, Competitive Landscape
21 Jan 2026 07:48 GMT
… Gains Momentum: Global Breast Cancer Subtyping Kits Market Projected … oncology shifts toward personalized treatment, subtyping kits have … rising global incidence of breast cancer, coupled with the … USD 49.5 billion breast cancer therapeutics market.
The …
-
Finding Hope and Support During Breast Cancer Treatment at Ochsner LSU Health – Monroe
21 Jan 2026 09:58 GMT
… Dawn T. learned she had breast cancer just one month after her … , Dawn found a team that treated her like family.
-
<![CDATA[FDA accepts NDA for gedatolisib, Celcuity’s investigational breast cancer treatment ]]>
21 Jan 2026 04:14 GMT
… carries particular importance for breast cancer care because HR+… is the most common breast cancer subtype, accounting for … growth, survival and treatment resistance in breast cancer. Unlike approved … and PIK3CA wild-type breast cancer cells. This broad …
-
Advances in the Prevention and Treatment of Radiation Skin Injury: Mechanisms, Pharmacological Interventions, and Applications of Novel Dressings
21 Jan 2026 08:13 GMT
… controlled trial in breast cancer patients undergoing radiotherapy … skin reactions in breast cancer patients’ post-radiotherapy … reduces skin reactions in breast cancer patients’ post-radiotherapy, … in breast cancer patients. Technol Cancer Res Treat. 2024 …
-
Fundraiser to benefit local woman recently diagnosed with breast cancer
21 Jan 2026 01:53 GMT
… come with treatment.
Strong was diagnosed with invasive ductal carcinoma (breast cancer) along …
-
<![CDATA[FDA Grants Priority Review to Gedatolisib for Advanced Breast Cancer]]>
21 Jan 2026 01:40 GMT
… , for the treatment of certain patients with advanced breast cancer.1 The regulatory … new treatment option to patients with HR+/HER2– advanced breast cancer,” said … the treatment of patients with advanced or metastatic HR+/HER2- breast cancer …
-
<![CDATA[FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer]]>
20 Jan 2026 22:44 GMT
… new treatment option to patients with HR+/HER2- advanced breast cancer,” Brian … confirmed metastatic or locally advanced breast cancer. Eligible patients had documented estrogen … treatment of patients with HR+/HER2-/PIK3CA-WT advanced breast cancer …
-
Cannabis-Infused Balms Reduce Pain for Patients with Breast Cancer
20 Jan 2026 22:08 GMT
… Cannabis and Cannabinoid Research showed breast cancer patients taking prescribed aromatase inhibitors … (THC) and cannabidiol (CBD).
Breast cancer is the most common cancer … Participants using THC-dominant topical treatments reported the greatest degree of …
-
Glycyrrhizin Boosts PTEN, Inhibits Breast Cancer Growth
20 Jan 2026 21:24 GMT
… breast cancer, …
Breast cancer … breast cancer cellular proliferationbreast cancer signaling pathwaysenhancing treatment modalities for breast cancerglycyrrhizin and breast cancerglycyrrhizin … breast cancermolecular interventions in breast cancernatural …
-
Psychosocial Adaptation in Breast Cancer Patients: A Mixed-Methods sequential Explanatory Study
20 Jan 2026 19:25 GMT
… treatment,6 seriously affecting breast cancer patients’ treatment adherence,7 treatment … treatment for breast cancer, and 93.1% of breast cancer survivors achieve survival through surgical treatment … breast cancer outcome: a systematic review. Breast Cancer …